These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
95 related items for PubMed ID: 16132615
1. Levamisole inhibits angiogenesis in vitro and tumor growth in vivo. Friis T, Engel AM, Klein BM, Rygaard J, Houen G. Angiogenesis; 2005; 8(1):25-34. PubMed ID: 16132615 [Abstract] [Full Text] [Related]
2. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells. Zhang GM, Zhang YM, Fu SB, Liu XH, Fu X, Yu Y, Zhang ZY. Chin Med J (Engl); 2008 Nov 20; 121(22):2324-30. PubMed ID: 19080341 [Abstract] [Full Text] [Related]
3. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1. Starzec A, Vassy R, Martin A, Lecouvey M, Di Benedetto M, Crépin M, Perret GY. Life Sci; 2006 Nov 17; 79(25):2370-81. PubMed ID: 16959272 [Abstract] [Full Text] [Related]
4. Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2. Oh HK, Ha JM, O E, Lee BH, Lee SK, Shim BS, Hong YK, Joe YA. Cancer Res; 2007 May 15; 67(10):4851-9. PubMed ID: 17510415 [Abstract] [Full Text] [Related]
5. Tumor anti-angiogenic effect and mechanism of action of delta-tocotrienol. Shibata A, Nakagawa K, Sookwong P, Tsuzuki T, Oikawa S, Miyazawa T. Biochem Pharmacol; 2008 Aug 01; 76(3):330-9. PubMed ID: 18599020 [Abstract] [Full Text] [Related]
7. Antineoplastic effects of chemotherapeutic agents are potentiated by NM-3, an inhibitor of angiogenesis. Reimer CL, Agata N, Tammam JG, Bamberg M, Dickerson WM, Kamphaus GD, Rook SL, Milhollen M, Fram R, Kalluri R, Kufe D, Kharbanda S. Cancer Res; 2002 Feb 01; 62(3):789-95. PubMed ID: 11830534 [Abstract] [Full Text] [Related]
8. Ganoderma tsugae extract inhibits expression of epidermal growth factor receptor and angiogenesis in human epidermoid carcinoma cells: In vitro and in vivo. Hsu SC, Ou CC, Chuang TC, Li JW, Lee YJ, Wang V, Liu JY, Chen CS, Lin SC, Kao MC. Cancer Lett; 2009 Aug 18; 281(1):108-16. PubMed ID: 19332363 [Abstract] [Full Text] [Related]
9. EPOX inhibits angiogenesis by degradation of Mcl-1 through ERK inactivation. Sun HL, Tsai AC, Pan SL, Ding Q, Yamaguchi H, Lin CN, Hung MC, Teng CM. Clin Cancer Res; 2009 Aug 01; 15(15):4904-14. PubMed ID: 19622586 [Abstract] [Full Text] [Related]
11. The vascular targeting property of paclitaxel is enhanced by SU6668, a receptor tyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibition of angiogenesis. Naumova E, Ubezio P, Garofalo A, Borsotti P, Cassis L, Riccardi E, Scanziani E, Eccles SA, Bani MR, Giavazzi R. Clin Cancer Res; 2006 Mar 15; 12(6):1839-49. PubMed ID: 16551869 [Abstract] [Full Text] [Related]
12. Alendronate suppresses tumor angiogenesis by inhibiting Rho activation of endothelial cells. Hashimoto K, Morishige K, Sawada K, Tahara M, Shimizu S, Ogata S, Sakata M, Tasaka K, Kimura T. Biochem Biophys Res Commun; 2007 Mar 09; 354(2):478-84. PubMed ID: 17240356 [Abstract] [Full Text] [Related]
13. Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer. Ischenko I, Guba M, Yezhelyev M, Papyan A, Schmid G, Green T, Fennell M, Jauch KW, Bruns CJ. Angiogenesis; 2007 Mar 09; 10(3):167-82. PubMed ID: 17486419 [Abstract] [Full Text] [Related]
14. Inhibition of in vivo angiogenesis by N-beta-alanyl-5-S-glutathionyl-3,4-dihydroxyphenylalanine. Nishikawa T, Akiyama N, Kunimasa K, Oikawa T, Ishizuka M, Tsujimoto M, Natori S. Eur J Pharmacol; 2006 Jun 13; 539(3):151-7. PubMed ID: 16725138 [Abstract] [Full Text] [Related]
15. Inhibition of tumor angiogenesis by targeting endothelial surface ATP synthase with sangivamycin. Komi Y, Ohno O, Suzuki Y, Shimamura M, Shimokado K, Umezawa K, Kojima S. Jpn J Clin Oncol; 2007 Nov 13; 37(11):867-73. PubMed ID: 17956898 [Abstract] [Full Text] [Related]
16. Inhibition of the phosphatidylinositol 3-kinase/Akt pathway by inositol pentakisphosphate results in antiangiogenic and antitumor effects. Maffucci T, Piccolo E, Cumashi A, Iezzi M, Riley AM, Saiardi A, Godage HY, Rossi C, Broggini M, Iacobelli S, Potter BV, Innocenti P, Falasca M. Cancer Res; 2005 Sep 15; 65(18):8339-49. PubMed ID: 16166311 [Abstract] [Full Text] [Related]
17. Selective blockade of vascular endothelial growth factor receptor 2 with an antibody against tumor-derived vascular endothelial growth factor controls the growth of human pancreatic adenocarcinoma xenografts. Holloway SE, Beck AW, Shivakumar L, Shih J, Fleming JB, Brekken RA. Ann Surg Oncol; 2006 Aug 15; 13(8):1145-55. PubMed ID: 16791450 [Abstract] [Full Text] [Related]
18. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo. Narita K, Staub J, Chien J, Meyer K, Bauer M, Friedl A, Ramakrishnan S, Shridhar V. Cancer Res; 2006 Jun 15; 66(12):6025-32. PubMed ID: 16778174 [Abstract] [Full Text] [Related]
19. Fumagillin inhibits colorectal cancer growth and metastasis in mice: in vivo and in vitro study of anti-angiogenesis. Hou L, Mori D, Takase Y, Meihua P, Kai K, Tokunaga O. Pathol Int; 2009 Jul 15; 59(7):448-61. PubMed ID: 19563408 [Abstract] [Full Text] [Related]
20. Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis. Pan Q, Kleer CG, van Golen KL, Irani J, Bottema KM, Bias C, De Carvalho M, Mesri EA, Robins DM, Dick RD, Brewer GJ, Merajver SD. Cancer Res; 2002 Sep 01; 62(17):4854-9. PubMed ID: 12208730 [Abstract] [Full Text] [Related] Page: [Next] [New Search]